NCT03487991

Brief Summary

We are evaluating a model where trauma exposure and threatening environments elicit nocturnal vigilance and sleep-related fears that compromise the healthy reduction of autonomic arousal during sleep which in turn stimulates secretion of atherogenic humoral factors, arterial stiffening, and cardiovascular disease risk. We will examine the roles of pre-sleep cognition using a questionnaire and real time assessment, and modifiable strategies for coping with sleep disruptive cognitions. We will then evaluate the impact of providing personalized feedback and recommendations based on study observations on how participants cope with potentially sleep disruptive cognitions and sleep efficiency in a randomized trial.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
168

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2017

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

March 28, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 4, 2018

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2021

Completed
Last Updated

April 4, 2018

Status Verified

March 1, 2018

Enrollment Period

4.1 years

First QC Date

March 28, 2018

Last Update Submit

March 28, 2018

Conditions

Keywords

autonomic balancesleependothelial functionbehaviorstress

Outcome Measures

Primary Outcomes (1)

  • sleep efficiency

    percent of time in bed spent asleep

    6 months

Secondary Outcomes (2)

  • normalized high frequency ratio of heart rate variability while in bed

    6 months

  • pulse wave velocity

    6 months

Study Arms (2)

personalized behavioral recommendations

EXPERIMENTAL

Will receive recommendations for altering sleep related behavior based on data from in-home monitoring.

Behavioral: Personalized sleep intervention

educational control

NO INTERVENTION

Will receive the data without recommendations. Will receive personalized recommendations after the follow up assessment.

Interventions

Personalized feedback and recommendations based on study observations of sleep behavior and how participants cope with potentially sleep disruptive cognitions on their frequency and impact and on sleep efficiency. A written report is provided to participants and their initial modifications are monitored.

personalized behavioral recommendations

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may not qualify if:

  • current medical or psychiatric condition that affects sleep or requires daily - use of medication other than PTSD, phobic disorders, or past history of major depression
  • severe alcohol or drug use disorders
  • overnight shift worker or an extreme chronotype
  • sleep disorder other than insomnia or nightmares
  • morbid obesity (body mass index \> 40)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinical Research Unit; Howard University Hospital

Washington D.C., District of Columbia, 20060, United States

RECRUITING

MeSH Terms

Conditions

Stress Disorders, Post-TraumaticSleep Initiation and Maintenance DisordersBehavior

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental DisordersSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Central Study Contacts

Travan Hurst, BA

CONTACT

Obisesan Yejide, BA

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 28, 2018

First Posted

April 4, 2018

Study Start

October 1, 2017

Primary Completion

October 31, 2021

Study Completion

October 31, 2021

Last Updated

April 4, 2018

Record last verified: 2018-03

Locations